BSE · HSIL.BO
Hemant Surgical Industries Ltd.
₹573.60-₹11.40 (-1.95%)
Hemant Surgical Industries Ltd.’s quoted price sits in the upper half of its reported 52-week range, 15.52% below the high.
Loading market information…
NSE · LOTUSEYE.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:59 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Lotus Eye Hospital and Institute Limited’s quoted price sits in the lower half of its reported 52-week range, 25.75% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Lotus Eye Hospital and Institute Limited’s forward annual dividend is ₹0.50 per share, paid annual. The forward yield is 0.46% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Lotus Eye Hospital and Institute Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and cornea infections, as well as various eye related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:54 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹573.60-₹11.40 (-1.95%)
Hemant Surgical Industries Ltd.’s quoted price sits in the upper half of its reported 52-week range, 15.52% below the high.
₹159.40-₹1.90 (-1.18%)
Asarfi Hospital Ltd.’s quoted price sits in the lower half of its reported 52-week range, 37.96% below the high.
₹106.26-₹4.58 (-4.13%)
Aarey Drugs & Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 7.44% below the high.
₹293.80-₹9.10 (-3.0%)
Nureca Limited’s quoted price sits in the upper half of its reported 52-week range, 21.86% below the high.
₹35.00₹0.00 (0.0%)
Ambalal Sarabhai Enterprises Limited’s quoted price sits in the lower half of its reported 52-week range, 29.97% below the high.
₹416.75+₹16.45 (+4.11%)
BDH Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 31.68% below the high.
₹97.95-₹7.05 (-6.71%)
Aashka Hospitals Limited’s quoted price sits in the upper half of its reported 52-week range, 9.31% below the high.
₹174.75+₹6.35 (+3.77%)
Sanjivani Paranteral Limited.’s quoted price sits in the lower half of its reported 52-week range, 28.38% below the high.
